Search Results - "Reddy, Neelima G"

Clinical Validation of a Next-Generation Sequencing Screen for Mutational Hotspots in 46 Cancer-Related Genes by Singh, Rajesh R, Patel, Keyur P, Routbort, Mark J, Reddy, Neelima G, Barkoh, Bedia A, Handal, Brian, Kanagal-Shamanna, Rashmi, Greaves, Wesley O, Medeiros, L. Jeffrey, Aldape, Kenneth D, Luthra, Rajyalakshmi

“…Transfer of next-generation sequencing technology to a Clinical Laboratory Improvement Amendments–certified laboratory requires vigorous validation. Herein, we…”
Get full text

Next-generation sequencing-based multi-gene mutation profiling of solid tumors using fine needle aspiration samples: promises and challenges for routine clinical diagnostics by Kanagal-Shamanna, Rashmi, Portier, Bryce P, Singh, Rajesh R, Routbort, Mark J, Aldape, Kenneth D, Handal, Brian A, Rahimi, Hamed, Reddy, Neelima G, Barkoh, Bedia A, Mishra, Bal M, Paladugu, Abhaya V, Manekia, Jawad H, Kalhor, Neda, Chowdhuri, Sinchita Roy, Staerkel, Gregg A, Medeiros, L Jeffrey, Luthra, Rajyalakshmi, Patel, Keyur P

“…Increasing use of fine needle aspiration for oncological diagnosis, while minimally invasive, poses a challenge for molecular testing by traditional sequencing…”
Get full text

Next-generation sequencing-based multigene mutational screening for acute myeloid leukemia using MiSeq: applicability for diagnostics and disease monitoring by Luthra, Rajyalakshmi, Patel, Keyur P, Reddy, Neelima G, Haghshenas, Varan, Routbort, Mark J, Harmon, Michael A, Barkoh, Bedia A, Kanagal-Shamanna, Rashmi, Ravandi, Farhad, Cortes, Jorge E, Kantarjian, Hagop M, Medeiros, L Jeffrey, Singh, Rajesh R

“…Routine molecular testing in acute myeloid leukemia involves screening several genes of therapeutic and prognostic significance for mutations. A comprehensive…”
Get full text

Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells by Cohen, Evan N, Gao, Hui, Anfossi, Simone, Mego, Michal, Reddy, Neelima G, Debeb, Bisrat, Giordano, Antonio, Tin, Sanda, Wu, Qiong, Garza, Raul J, Cristofanilli, Massimo, Mani, Sendurai A, Croix, Denise A, Ueno, Naoto T, Woodward, Wendy A, Luthra, Raja, Krishnamurthy, Savitri, Reuben, James M

“…Inflammatory breast cancer (IBC) is the most insidious form of locally advanced breast cancer; about a third of patients have distant metastasis at initial…”
Get full text

Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified Setting by Morris, Jeffrey S, Luthra, Rajyalakshmi, Liu, Yusha, Duose, Dzifa Y, Lee, Wonyul, Reddy, Neelima G, Windham, Justin, Chen, Huiqin, Tong, Zhimin, Zhang, Baili, Wei, Wei, Ganiraju, Manyam, Broom, Bradley M, Alvarez, Hector A, Mejia, Alicia, Veeranki, Omkara, Routbort, Mark J, Morris, Van K, Overman, Michael J, Menter, David, Katkhuda, Riham, Wistuba, Ignacio I, Davis, Jennifer S, Kopetz, Scott, Maru, Dipen M

“…Consensus molecular subtyping (CMS) of colorectal cancer has potential to reshape the colorectal cancer landscape. We developed and validated an assay that is…”
Get full text

Predictors of Primary Imatinib Resistance in Chronic Myelogenous Leukemia Are Distinct From Those in Secondary Imatinib Resistance by ZHANG, Wenyong W, CORTES, Jorge E, HUI YAO, LI ZHANG, REDDY, Neelima G, JABBOUR, Elias, KANTARJIAN, Hagop M, JONES, Dan

“…A subset of patients with chronic myelogenous leukemia (CML) do not respond to the tyrosine kinase inhibitor (TKI) imatinib mesylate. Such primary imatinib…”
Get full text

Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells: e0132710 by Cohen, Evan N, Gao, Hui, Anfossi, Simone, Mego, Michal, Reddy, Neelima G, Debeb, Bisrat, Giordano, Antonio, Tin, Sanda, Wu, Qiong, Garza, Raul J

“…Inflammatory breast cancer (IBC) is the most insidious form of locally advanced breast cancer; about a third of patients have distant metastasis at initial…”
Get full text